KRAS and neoplasm: Our previous tissue genome studies revealed that alterations in APC and KRAS appeared earlier during the formation of adenoma, whereas mutations in TP53, PIK3CA and SMAD4 were acquired for tumor transformation and play driver roles in tumor biology [11].